Insights Into the Landmark CheckMate 816 Trial

This latest episode of Thinking Thoracic, an STS podcast, features host Erin Gillaspie, MD, in conversation with Jonathan Spicer, MD, a leading thoracic oncologist and clinical trial investigator. The two dive into the landmark CheckMate 816 trial, which helped usher in a new era for immunotherapy in lung cancer treatment. Dr. Spicer shares insights on trial design, clinical outcomes, and what these findings mean for the future of thoracic surgery and oncology. Listen today.